A number of other research analysts also recently weighed in on the company. JPMorgan Chase & Co. set a €87.70 ($108.27) price target on Gerresheimer and gave the company a buy rating in a research note on Thursday, January 4th. Credit Suisse Group set a €75.00 ($92.59) price objective on Gerresheimer and gave the company a buy rating in a report on Wednesday, February 21st. Deutsche Bank set a €64.00 ($79.01) price objective on Gerresheimer and gave the stock a neutral rating in a report on Friday, December 1st. Hauck & Aufhaeuser set a €55.00 ($67.90) target price on shares of Gerresheimer and gave the company a sell rating in a research report on Wednesday, January 24th. Finally, equinet set a €75.00 ($92.59) target price on shares of Gerresheimer and gave the stock a neutral rating in a research report on Friday, January 19th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company’s stock. Gerresheimer currently has a consensus rating of Hold and a consensus price target of €69.85 ($86.24).
Gerresheimer (ETR GXI) traded up €1.55 ($1.91) during trading on Thursday, hitting €67.00 ($82.72). The stock had a trading volume of 86,147 shares, compared to its average volume of 140,278. The stock has a market capitalization of $2,100.00 and a PE ratio of 20.87. Gerresheimer has a twelve month low of €59.97 ($74.04) and a twelve month high of €78.25 ($96.60).
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.